VanEck Pharmaceutical ETF Rating $92.13 +0.28 (+0.30%) Closing price 10/15/2025 04:00 PM EasternExtended Trading$92.08 -0.05 (-0.05%) As of 10/15/2025 06:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock VanEck Pharmaceutical ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PPH Aggregate RatingModerate Buy 2.56Holdings in PPH have an aggregate rating of Moderate Buy based on 309 analyst ratings issued in the past year covering 23 companies (90.2% of the portfolio).PPH Aggregate Price Target$92.13High Prediction$92.13Average Prediction$92.13Low Prediction$92.13Holdings in PPH have an aggregate price target of $92.13 and a range of $92.13 to $92.13 covering 23 companies (90.2% of the portfolio).PPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Pharmaceutical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 PPH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings20.63%LLYEli Lilly and Company$826.20+1.7%4.9964 of 5 stars2.68$948.06 14.7%25Trending NewsAnalyst UpgradeAnalyst Revision7.89%NVONovo Nordisk A/S$56.72+0.1%4.4383 of 5 stars2.50$76.00 34.0%20Trending NewsAnalyst Forecast7.65%MRKMerck & Co., Inc.$84.11-0.7%4.9978 of 5 stars2.29$105.00 24.8%21Trending NewsAnalyst ForecastAnalyst Revision5.23%PFEPfizer$24.39-0.5%4.9768 of 5 stars2.37$28.35 16.2%19Trending NewsDividend AnnouncementAnalyst Revision4.78%ABBVAbbVie$226.31-1.2%4.6447 of 5 stars2.71$231.90 2.5%28Trending NewsAnalyst ForecastOptions VolumeAnalyst Revision4.61%GSKGSK$43.81-0.8%2.0634 of 5 stars1.88$37.38 -14.7%8Dividend CutGap Down4.59%MCKMcKesson$791.40+1.2%4.7861 of 5 stars2.88$834.54 5.5%17Positive NewsAnalyst Forecast4.54%SNYSanofi$48.96-0.5%4.184 of 5 stars3.00$62.67 28.0%10Analyst Revision4.52%JNJJohnson & Johnson$190.96+0.1%4.7513 of 5 stars2.73$199.59 4.5%22Trending NewsEarnings ReportDividend AnnouncementAnalyst Forecast4.42%AZNAstraZeneca$84.83-0.3%2.7739 of 5 stars2.80$86.00 1.4%54.19%ZTSZoetis$142.08-1.0%4.7658 of 5 stars2.44$196.71 38.5%9Trending NewsDividend AnnouncementAnalyst Revision4.14%BMYBristol Myers Squibb$43.63-0.4%4.9862 of 5 stars2.33$57.14 31.0%21Analyst ForecastAnalyst Revision3.51%CORCencora$320.02+0.7%4.2525 of 5 stars2.75$320.00 0.0%12Positive News2.77%HLNHaleon$9.21+0.4%3.9833 of 5 stars2.50$12.33 33.9%102.48%TAKTakeda Pharmaceutical$13.86+0.4%2.6541 of 5 stars2.003Analyst Forecast1.70%TEVATeva Pharmaceutical Industries$19.80-1.6%3.3039 of 5 stars3.00$25.57 29.2%90.58%VTRSViatris$9.98+0.5%2.3306 of 5 stars1.86$11.17 11.9%7News CoverageAnalyst Forecast0.53%JAZZJazz Pharmaceuticals$135.80+1.5%4.6063 of 5 stars2.76$178.93 31.8%17Analyst Revision0.43%ELANElanco Animal Health$20.52+1.5%2.6575 of 5 stars2.91$19.14 -6.7%11Analyst Revision0.41%CORTCorcept Therapeutics$76.81+6.5%4.9001 of 5 stars2.57$135.25 76.1%7Insider Trade0.30%AXSMAxsome Therapeutics$129.58+4.9%4.7101 of 5 stars3.00$177.93 37.3%17Analyst Revision0.17%OGNOrganon & Co.$9.55-0.1%4.8073 of 5 stars2.50$17.33 81.5%60.14%PRGOPerrigo$21.38-1.3%4.9036 of 5 stars2.20$34.00 59.0%5 This page (NASDAQ:PPH) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredBuy this stock before Tesla’s November 6 announcementThe End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Pharmaceutical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
